Day One Biopharmaceuticals (DAWN) Earnings (2020 - 2025)
Day One Biopharmaceuticals (DAWN) earnings from Mar 31, 2020 to Dec 31, 2025. The TTM Day One Biopharmaceuticals (DAWN) earnings is -$107M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Day One Biopharmaceuticals (DAWN) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +12.40% |
| 3 Years TTM | -8.95% |
| 5 Years TTM | +21.52% |
| All Time TTM | +15.48% |
Annual Earnings change of Day One Biopharmaceuticals (DAWN)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$107M | +12.38% |
| 2024 | -$96M | -49.45% |
| 2023 | -$189M | +32.87% |
| 2022 | -$142M | +95.44% |
| 2021 | -$73M | +79.59% |
| 2020 | -$41M | +220.74% |
| 2019 | -$13M | N/A |
Comparison Day One Biopharmaceuticals (DAWN) five years earnings CAGR with competitors
Day One Biopharmaceuticals (DAWN) five years earnings CAGR is 21.52%.